NACSYS® Hospital Tenders Awarded

ALTURiX Ltd are pleased to announce that NACSYS has been awarded hospital contract supplier status for acetylcysteine 600mg effervescent tablets (DHF 021) for CESW (CCM/PHG/17/5532/02), LSNE (CM/PHG/17/5532/02) and NWLN (CM/PHG/17/5532/02).  These tenders… Read More

CEYESTO® Hospital Tenders Awarded

ALTURiX Ltd are pleased to announce that CEYESTO Melatonin 3mg tablets have been recently awarded contracts for DLD014 Melatonin Tablets 3mg Pack/30 for the CESW and… Read More

CEYESTO Launch: November 1st

ALTURiX Ltd are pleased to announce the launch of CEYESTO® Melatonin 3mg tablets.  An additional option in the treatment of adult jet lag is… Read More

May COVID-19 Update

The world continues to face the challenges of the global threat from COVID-19, and we at ALTURiX continue to do everything we can to play… Read More

COVID-19 Update

The ALTURiX mission is to provide medicines value, and to do so reliably to help the NHS improve patient outcomes. Never has this been more… Read More

ALTURiX Launches

Announced today, ALTURiX – a new British company – has conditionally acquired the rights to a portfolio of well-known medicines which are prescribed widely by the… Read More

UK Wholesaler Agreements

HK Pharma and Atlantic Pharma are pleased to announce new three-year distribution agreements for their products with Alliance Healthcare UK, and PHOENIX. From 1st June… Read More